These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11270587)

  • 1. Role of the sympathetic nervous system in cardiac remodeling in hypertension.
    Iaccarino G; Barbato E; Cipoletta E; Fiorillo A; Trimarco B
    Clin Exp Hypertens; 2001; 23(1-2):35-43. PubMed ID: 11270587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic activity and myocardial anatomy and function in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of adrenergic alpha- and beta-receptors in the pathogenesis of hypertension and heart disease].
    Brodde OE
    Internist (Berl); 1988 Jun; 29(6):397-413. PubMed ID: 2841255
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac function as related to adrenergic activity in hypertensive left ventricular hypertrophy.
    Agabiti-Rosei E; Muiesan ML; Romanelli G; Castellano M; Beschi M; Alicandri C; Muiesan G
    J Clin Hypertens; 1987 Jun; 3(2):203-10. PubMed ID: 3039076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy.
    Ostman-Smith I
    Clin Sci (Lond); 1981 Sep; 61(3):265-72. PubMed ID: 6266734
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic pathways and left ventricular remodeling.
    Dorn GW
    J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
    Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
    Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asymmetric septal hypertrophy in essential hypertension and sympathetic nervous system].
    Kumagai E; Nomura G; Midorikawa K; Koga Y
    Kokyu To Junkan; 1983 Jan; 31(1):63-6. PubMed ID: 6222450
    [No Abstract]   [Full Text] [Related]  

  • 9. Peripheral adrenergic system and hypertension.
    Veglio F; Morra di Cella S; Schiavone D; Paglieri C; Rabbia F; Mulatero P; Chiandussi L
    Clin Exp Hypertens; 2001; 23(1-2):3-14. PubMed ID: 11270586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adrenergic receptor systems in canine left ventricular hypertrophy.
    Chiba M; Shida M; Miyazaki Y; Koga Y; Toshima H
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():39-47. PubMed ID: 2560796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sympathetic-adrenal system and myocardial hypertrophy in patients with hypertension].
    Amirbegishvili TV; Kiseleva ZM
    Klin Med (Mosk); 1987 Jul; 65(7):52-4. PubMed ID: 2959816
    [No Abstract]   [Full Text] [Related]  

  • 12. Presynaptic alpha- and beta-adrenoceptor stimulation and norepinephrine release in the spontaneously hypertensive rat.
    Ekas RD; Steenberg ML; Woods MS; Lokhandwala MF
    Hypertension; 1983; 5(2):198-204. PubMed ID: 6298101
    [No Abstract]   [Full Text] [Related]  

  • 13. Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension.
    Chang PC; Kriek E; van Brummelen P
    J Hypertens; 1994 Feb; 12(2):179-90. PubMed ID: 8021470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects.
    Bühler FR; Kiowski W; van Brummelen P; Amann FW; Bertel O; Landmann R; Lütold BE; Bolli P
    Clin Exp Hypertens (1978); 1980; 2(3-4):409-26. PubMed ID: 6253240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.
    Ram CV
    J Hypertens Suppl; 1989 Dec; 7(6):S98-9. PubMed ID: 2576672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice.
    Du XJ
    Cardiovasc Res; 2001 Jun; 50(3):443-53. PubMed ID: 11376620
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of alpha- and beta-adrenergic receptor stimulation in the genesis of arrhythmias during myocardial ischaemia.
    Yamada KA; Saffitz JE; Corr PB
    Eur Heart J; 1986 May; 7 Suppl A():85-90. PubMed ID: 2873040
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of the sympathetic nervous system in essential arterial hypertension and organ damage].
    Grassi G; Mancia G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():115S-120S. PubMed ID: 8562257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of G-proteins in altered beta-adrenergic responsiveness in the failing and hypertrophied myocardium.
    Böhm M; Flesch M; Schnabel P
    Basic Res Cardiol; 1996; 91 Suppl 2():47-51. PubMed ID: 8957544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.